Recent scientific investigations have unveiled a concerning correlation between the pervasive presence of microplastics in the environment and the rising…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, fortified by a prestigious pan-European EUREKA grant, has been officially launched to pioneer the development of…
Read More
Sanofi Secures Global Rights to Kali Therapeutics’ Promising Tri-Specific Antibody KT501 for Autoimmune Diseases in a Landmark $1.23 Billion Deal
Sanofi has entered into an exclusive global license agreement with Kali Therapeutics, a significant move that grants the pharmaceutical giant…
Read More
Gilead Sciences to Acquire Ouro Medicines for $2.2 Billion, Ushering in New Era of T-Cell Engagers in Autoimmune Diseases
Gilead Sciences is poised to make a significant entry into the burgeoning field of T-cell engagers (TCEs) with its $2.2…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…
Read More
Scientific Study Unveils Five Biological Pathways Linking Microplastics to Neurodegenerative Diseases Like Alzheimers and Parkinsons
The global proliferation of plastic pollution has moved beyond an environmental crisis into the realm of a significant public health…
Read More
